TP53 and neoplasm: Biopsy specimens pre- and post-treatment of either arm IDA or arm COBI were examined for expression of the cyclin dependent kinase inhibitor p21, a marker of p53 activity, tumor-specific HLA-A/B/C, and immune signature data.